Management Change24 Aug 2026, 07:31 pm
Eiko Lifesciences Appoints Suraj Mahadev Gaikwad as Additional Director
AI Summary
Eiko Lifesciences Ltd has announced the appointment of Mr. Suraj Mahadev Gaikwad as an Additional Director (Independent and Non-Executive). The appointment was approved by the Board of Directors on August 24, 2026. Mr. Gaikwad will hold the office until the ensuing Annual General Meeting, after which he will serve as an Independent Director for a term of 5 years, subject to shareholder approval. He is a Commerce Graduate with over 7 years of experience in accountancy and business management, bringing expertise in financial operations and strategic planning. This appointment is in compliance with SEBI Listing Regulations.
Key Highlights
- Mr. Suraj Mahadev Gaikwad appointed as Additional Independent Director.
- Appointment effective from August 24, 2026, pending shareholder approval.
- Director to serve a 5-year term post-AGM.
- Gaikwad brings 7+ years of experience in accountancy and management.
- No disclosed relationship with existing directors.
Price Impact
More from EIKO